IncFact
Company Profiles: Revenue, Growth, Competition

NANOSTRING TECHNOLOGIES Revenue, Growth & Competitor Profile

Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Nanostring Technologies

Access the complete profile.

Nanostring Technologies Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry339112 Surgical & Medical Instrument Manufacturing
Additional NAICS Codes33
334516 Analytical Laboratory Instrument Manufacturing
33911
Address530 Fairview Ave N.
Seattle, WA 98109

www.nanostring.com


Nanostring Technologies's annual revenues are $100-$500 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Surgical & Medical Instrument Manufacturing industry.


Nanostring Technologies's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Nanostring Technologies is a publicly traded company on NGM using the ticker symbol NSTG. Detailed information on company financials and operating reports can be found here: NGM: NSTG



Nanostring Technologies Annual Revenue and Growth Rate

Nanostring Technologies Revenue Est.
($ Million)
Growth Rate (%)# Employees
2019 Details in Premium Report
2018
2017
2016
2015
2014


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Nanostring Technologies's revenues are gauged from an analysis of company filings.



Investor Activity

Nanostring Technologies has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
May 13, 2013 2 100%$0 MM
Complete list of funding rounds and total amounts in the Company Report




Trademark Applications

Trademark applications show the products and services that Nanostring Technologies is developing and marketing. Nanostring Technologies doesn't have any recent trademark applications, indicating Nanostring Technologies is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
GEOMX
reagents and instruments for scientific, research or diagnostic use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; diagnostic reagents for scientific or research use in the fields of cancer, neurology and infectious disease; reagents for scientific, research or diagnostic use relating to molecular identification and digital quantification; reagents for scientific, research or diagnostic use containing antibodies and nucleic acids; reagent kits comprising primarily reagents for scientific, research or diagnostic use in the fields of cancer, neurology and infectious disease; reagents for immuno-histochemistry detection and in situ-hybridization detection for scientific, research or diagnostic use; test kits for scientific, research or diagnostic use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation, namely, instructional manuals, therefor; test kits comprising reagents for scientific, research or diagnostic use relating to molecular identification and digital quantification; reagents for in vitro use in clinical chemistry and molecular biology; reagents for clinical or medical laboratory use, namely, reagents for pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling, nucleic acid sequencing, and clinical, oncology, neurology, and infectious disease diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers
05/09/2018
LYMPHMARK
diagnostic reagents for scientific or research use in the field of cancer, namely, lymphomas including diffuse large B-cell lymphoma; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer, namely, lymphomas including diffuse large B-cell lymphoma
09/05/2017
IO SELECT
diagnostic reagents for scientific or research use in the field of cancer including anal, biliary, neuroendocrine, endometrial, cervical, vulvar, small cell lung, mesothelioma, thyroid and salivary gland carcinoma cancers; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer including anal, biliary, neuroendocrine, endometrial, cervical, vulvar, small cell lung, mesothelioma, thyroid and salivary gland carcinoma cancers
09/05/2017

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Nanostring Technologies grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Nanostring Technologies is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Surgical & Medical Instrument Manufacturing

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Nanostring Technologies's Largest Competitors

A competitive analysis shows these companies are in the same general field as Nanostring Technologies, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
GAUMARD SCIENTIFICMiami, FL100 
LIFESCANMalvern, PA37 
BIODERMLargo, FL8 
PROVIDENCE MEDICAL TECHNOLOGYPleasanton, CA8 
MAGNOLIA MEDICAL TECHNOLOGIESSeattle, WA6 
ARMAMENTARIUMSpring, TX4 
ALTA MEDICAL SPECIALTIESSalt Lake City, UT4 
MEDI-DYNE HEALTH CARE PRODUCTS LTDColleyville, TX3 
METASYSTEMS GROUPNewton, MA3 




Nearby Competitors

These companies are similar in business line and location to Nanostring Technologies. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
NANOSTRING TECHNOLOGIESSeattle, WA100 
RARECYTESeattle, WA15 
MAGNOLIA MEDICAL TECHNOLOGIESSeattle, WA9 
BODYPOINT DESIGNSSeattle, WA7 
HOHMANNSeattle, WA5 
BENESOLBainbridge Island, WA4 




Future Competition: Nanostring Technologies's Fastest Growing Competitors

These companies are in the same general field as Nanostring Technologies and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Nanostring Technologies Competitors